Vedolizumab (anti-α4β7-integrin)
Product Specifications
CAS Number
943609-66-3
Synonyms
Entyvio
SKU
C00044-1mg
Target
Integrin
Applications
Cytoskeletal Signaling
Additionnal Information
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1221026-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O7:K1 Cysteine desulfuration protein sufE (sufE)
Ask
View Details MBS1221026-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O7:K1 Cysteine desulfuration protein sufE (sufE)
Ask
View Details 
MBS1221026-03 0.02 mg (Yeast)
Recombinant Escherichia coli O7:K1 Cysteine desulfuration protein sufE (sufE)
Ask
View Details MBS1221026-04 0.1 mg (Yeast)
Recombinant Escherichia coli O7:K1 Cysteine desulfuration protein sufE (sufE)
Ask
View Details